Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

Ozempic (semaglutide) is a subcutaneous injection ... Note that Ozempic has a boxed warning about the risk of thyroid cancer. A boxed warning is the most serious warning from the Food and Drug ...

The EMA, as well as the FDA in the US, have approved labelling for Wegovy that mentions that semaglutide has been ... people with a family history of thyroid cancer. In a statement, the EMA ...

In 2023, research on mice and rats suggested semaglutide — the powerful ingredient behind Wegovy and Ozempic — could raise the risk of one type of thyroid cancer: medullary thyroid cancer (MTC).

Typically, semaglutide is subcutaneously administered ... gallbladder disease, medullary thyroid cancer, or type 2 multiple endocrine neoplasia were excluded from the study. Participants ...

The type 2 diabetes medication, generically known as semaglutide, has received unprecedented ... for conditions ranging from heart disease to cancer to neurodegenerative diseases.

Still, definitely tell your healthcare provider if you have a personal or family history of thyroid cancer before starting semaglutide treatment. It’s possible to experience significant ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient ... If you have conditions like kidney disease or a history of thyroid cancer, GLP-1 agonists may not be suitable ...